WhiteOak Capital Pharma and Healthcare Fund Regular Growth

+

Equity
Sector - Healthcare
Rating N.A.
Plan

12.70 +0.12 (0.95%) NAV as on 17 Apr, 2025

5D
1M
6M
1Y
5Y
MAX

Key Metrics

AUM (in Cr)303.62
CAGR 26.81%
Exit Load1.00%
Expense ratio2.37%
CategoryEquity
Min Investment500
Min SIP100
Launch Date2024-02-06

Asset Allocation

Holdings As On - 21 April 2025

Holdings

Sectors

Name
Value (Cr)
Holding %

Cipla
22.45
7.39%

Divis Laboratories
18.47
6.08%

Lupin
16.93
5.58%

Fortis Healthcare
11.58
3.81%

Laurus Labs
10.77
3.54%

Piramal Pharma
8.27
2.72%

Peer Comparison

Fund Name
ITI Pharma and Healthcare Fund Regular Growth16.34%
Kotak Healthcare Fund Regular Growth14.42%
Quant Healthcare Fund Regular Growth4.92%
WhiteOak Capital Pharma and Healthcare Fund Regular Growth26.81%
PGIM India Healthcare Fund Regular Growth0%

Risk & Volitility

Alpha 0.00%
Beta 0.00
Sharpe Ratio0.00
Std Deviation 0.00%
Tracking Error 0.00%

About Fund

The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. However, there can be no assurance that the investment objective of the Scheme will be realized.

The WhiteOak Capital Pharma and Healthcare Fund Regular Growth has an AUM of 303.62 crores & has delivered CAGR of 0.00% in the last 5 years. The fund has an exit load of 1.00% and an expense ratio of 2.37%. The minimum investment in WhiteOak Capital Pharma and Healthcare Fund Regular Growth is Rs 500 and the minimum SIP is Rs 100.

As per morningstar the risk & return rating of the fund are Medium & Exceptional respectively.

The top holdings of the fund include Sun Pharmaceutical Industries, Cipla, Divis Laboratories & Lupin.

The major sectors where the fund is invested are Biotechnology & Drugs, Healthcare Facilities, Chemical Manufacturing & Major Drugs.

Some of the similar funds are ITI Pharma and Healthcare Fund Regular Growth, Kotak Healthcare Fund Regular Growth, Quant Healthcare Fund Regular Growth, WhiteOak Capital Pharma and Healthcare Fund Regular Growth, PGIM India Healthcare Fund Regular Growth. WhiteOak Capital Pharma and Healthcare Fund Regular Growth has a sharpe ratio of 0.00 & a standard deviation of 0.00%.